Genetic diversity, transmission dynamics and drug resistance of Mycobacterium tuberculosis in Angola

Sci Rep. 2017 Feb 23:7:42814. doi: 10.1038/srep42814.

Abstract

Tuberculosis (TB) poses a serious public health problem in Angola. No surveillance data on drug resistance is available and nothing is known regarding the genetic diversity and population structure of circulating Mycobacterium tuberculosis strains. Here, we have genotyped and evaluated drug susceptibility of 89 Mycobacterium tuberculosis clinical isolates from Luanda. Thirty-three different spoligotype profiles corresponding to 24 different Shared International Types (SIT) and 9 orphan profiles were detected. SIT 20 (LAM1) was the most prevalent (n = 16, 18.2%) followed by SIT 42 (LAM9; n = 15, 17.1%). Overall, the M. tuberculosis population structure in this sample was dominated by LAM (64.8%) and T (33.0%) strains. Twenty-four-loci MIRU-VNTR analysis revealed that a total of 13 isolates were grouped in 5 distinct clusters. Drug susceptibility data showed that 22 (24.7%) of the 89 clinical isolates were resistant to one or more antibacillary drugs of which 4 (4.5%) were multidrug resistant. In conclusion, this study demonstrates a high predominance of LAM strains circulating in the Luanda setting and the presence of recent transmission events. The rate and the emergence dynamics of drug resistant TB found in this sample are significant and highlight the need of further studies specifically focused on MDR-TB transmission.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angola / epidemiology
  • Anti-Bacterial Agents / pharmacology
  • Antitubercular Agents / pharmacology
  • DNA, Bacterial / genetics*
  • Drug Resistance, Multiple, Bacterial*
  • Evolution, Molecular
  • Female
  • Genetic Variation*
  • Genotyping Techniques
  • Humans
  • Microbial Sensitivity Tests
  • Mycobacterium tuberculosis / classification*
  • Mycobacterium tuberculosis / drug effects
  • Mycobacterium tuberculosis / genetics
  • Mycobacterium tuberculosis / isolation & purification
  • Phylogeny
  • Tuberculosis, Multidrug-Resistant / transmission*

Substances

  • Anti-Bacterial Agents
  • Antitubercular Agents
  • DNA, Bacterial